2020 Virtual Annual Meeting
& Upcoming Events
|
|
Our Annual Meeting is coming up and we want you to join us! Earlier this week, we sent you an email featuring two of the panels we're hosting, but you can check out the full agenda on our website. On Tuesday morning we'll have panels on responding to COVID-19 and the impact of pricing and policy on therapeutic innovation. Then on Wednesday, we'll have sessions on new frontiers in real world evidence as well as the rise of digital therapeutics. We'll also have a fireside chat with Dr. Michelle McMurry-Heath and Dr. Jeremy Levin.
While we may not be able to meet in person, we'll be hosting two evening receptions where you'll be connected with small groups of attendees via Zoom. You'll be able to talk with other industry professionals and network. We hope you will join us!
NewYorkBIO members receive a discount on registration. Put your membership to good use and reserve your spot today!
|
|
Virtual Breakfast Series
Thursday, September 10th, 10:00am ET
|
|
|
|
Meg Fitzgerald
Join us for the special Thursday installment of our Virtual Breakfast Series where we sit down with Meg Fitzgerald, an investor, executive, a global healthcare operator, and academic who has worked in every domain of healthcare from front line patient care through the Fortune 500 while serving as an Adjunct Associate Professor at Columbia University.
|
|
Meghan FitzGerald is a global healthcare operator, strategist, investor and academic. She has worked in every domain of healthcare from front line patient care through the Fortune 500 while serving as an Associate Professor at Columbia University.
Currently Meg serves as a Senior Advisor to L1 Private Equity an international investment firm with $25 billion of capital under management. Meg led L1’s Health’s inaugural investment vehicle focused on biopharma and healthcare services allocating over ~$3B in spend to date. And she just joined Goldman Sachs’ flagship private equity platform as a strategic advisory board member.
Prior to this Meg spent nearly twenty years in Corporate America working for many prominent healthcare companies. She was the EVP of Strategy, M&A and Health Policy at Cardinal Health (CAH) and a member of the executive committee. Before she was the President of Cardinal Health Specialty Solutions, one of the fastest growing businesses where her team took an underperforming division from $700mm USD to over $8BUSD in four years.
Meg was the SVP of New Markets and Business Development at Medco Health Solutions (MHS). She previously held positions in strategy and marketing at top companies including Pfizer, Merck and Sanofi-Synthelabo.
She is a member of the board of directors at Tenet Healthcare (THC) a leading Fortune 200 healthcare services company, Seniorlink a service platform supporting caregivers in the home and K2HealthVentures a life science investment fund where she is Chair and a founding partner. Meg just completed her third private equity deal with the acquisition of Destination Pet, a global pet care company where she is also Chair. In addition, she volunteers at her local hospital and for TrekMedics, a global nonprofit dedicated to bringing emergency care from Haiti to Tanzania.
Meg obtained a Doctor of Public Health (DrPH) at New York Medical College, focusing on health policy and the social determinants of health. She earned a Master of Public Health from Columbia University and a Bachelor of Nursing from Fairfield University. Currently, Meg teaches strategy and “The Business of Healthcare” at Columbia University in New York. Her new book “Ascending Davos: A career journey from the emergency room to the board room” was just launched by Forbes Books.
Meg is a lifelong runner, extreme sports enthusiast and mixed martial arts fan. She resides in the West Village of New York and Naples, Florida with her husband Michael Darda, a Wall Street Macro Strategist and their Weimaraner dogs Hailey and Claus.
|
|
Last Call: Nominations for Buzz of BIO
Applications Due Today, September 4th
|
|
|
|
Today is the last day to nominate your company for the Buzz of BIO Contest. This is a good fit for a company seeking a next round of financing or hoping to make the valuable connection needed to take your product into the next phase. Ten biotechs will be nominated in each of the three categories: Early Stage Entrepreneur, Late Stage Leader, and Diagnostics and Beyond. |
|
Visit the Buzz of BIO webpage to learn more about how to apply and the voting process. Don't wait, nominations are due today, Friday, September 4th.
|
|
Webinar | Let's Talk About It: A Seat at the Table
Wednesday, September 9, 1:00pm
|
|
|
|
NewYorkBIO is proud to be a community partner of LaunchBio's "Let's Talk About It" webinar series. On this panel called "A Seat at the Table," you will hear from top VC's and Entrepreneurs of color. They will share their experiences working in life sciences, discuss the challenges they faced, and how the industry will benefit from being more inclusive. |
|
 |
PSCBiotech Webinar: Disinfectant Efficacy
September 24
PSCBiotech is bringing you a webinar about the fundamentals of disinfectant efficacy tests. Host Crystal Booth will take you through the basics of the Assay test, what it's used for and regulations governing the test
as well as developing and preforming the method of testing.
Join them virtually on September 24th, at 1:00pm. Click below to register!
|
|
|
|
ShareVault Webinar
September 17
Our friends at ShareVault are hosting a webinar to help you navigate the challenges businesses are facing due to COVID-19. They'll be talking about topics like restructuring opportunities both in and out of court that will mitigate business disruptions. Join to talk about the health and survival of companies today and in the future.
Join them on September 17th at noon eastern.
|
|
|
|
FRAXA BioTech Games
September 10
The FRAXA Research Foundation is hosting their BioTech games virtually this September, and you can join! Form a team with your biotech colleagues to compete in online trivia and team building games. You can create a team video and take part in the challenge too.
Fragile X is the most common cause of inherited autism and intellectual disabilities. Proceeds benefit FRAXA Research Foundation, supporting Fragile X research projects at institutions around the world, including MIT, Harvard, Stanford and UCSD.
|
|
ShareVault's Business Solutions
Can you support remote clinical trial monitoring?
ShareVault can help!
The industry is under pressure to advance clinical trials in a radically skewed business landscape. Site visits may not be possible given travel restrictions and health and safety regulations.
During these unprecedented times, ShareVault can help sponsors verify compliance with clinical trial protocols.
ShareVault’s solution for managing and monitoring clinical trials remotely offers the following benefits:
- Robust security, granular access controls, and audit trail features to protect and manage confidential content wherever it travels.
- AES-256 encryption, safeguard confidential trial site content shared between sponsors, CROs and CRAs during monitoring, review and reporting as required by the Trial Monitoring Plan.
- HIPAA, HITRUST, 21CFR11 compliant with eTMF requirement and integrated e-signature certification.
- Always-on availability mitigates risk related to clinical trial delays and disruption.
Rest assured you can secure any file shared externally for applications such as, but not limited to remote clinical trial management, fundraising, partnering, licensing, and board collaboration.
Contact ShareVault to learn more or watch the webinar
|
|
Partnering with BIO to engage biotech in the election |
|
|
|
As you know, the election is fast approaching and so is the deadline to register to vote. In New York, voters must register by October 9th to vote in the November 3rd election. We've partnered with BIO to give you all the information you need to engage. Click here to confirmed that you are registered to vote, to learn about your candidates, and biotech's policy priorites.
|
|
To help make sure you're informed about the elections, BIO is hosting a webinar on September 14th at 1:00pm. The expert panel will provide additional insight into the likely events that might shape the election’s final outcome as well as the policy outlooks under both a second Trump term or a Biden presidency. Register to join the webinar below!
|
|
|
|
|
|
|
|
